We are pleased to share that our collaborative paper, “PET Imaging of Accessible PSMA Reveals Dose-Dependent and Tumor Burden-Driven Variability,” has been accepted for publication in The Journal of Nuclear Medicine. The study, led by colleagues at Johns Hopkins University, shows how [18F]DCFPyL PET imaging can quantify accessible PSMA after antibody treatment and help optimize dosing of PSMA-targeted antibody therapeutics. Our team contributed to this work through its expertise in PSMA biology and antibody reagents, including the anti-PSMA antibody 5D3. Congratulations to all collaborators on this exciting translational advance!
